ProteoFormiX is a Belgium based life science innovator running a high-performance mass spectrometry (MS) based technology platform dedicated to the analysis and identification of disease and health associated proteoforms (i.e. specific molecular forms of protein products arising from identified genes) in liquid and tissue biopsies. Primarily concentrating on the identification of biologically and biomedically relevant peptides directly fromtissues (diseased and healthy), ProteoFormiX aims to detect undiscovered biomarkers such as in the search for innovative diagnostics. ProteoFormiX was founded by Prof. Dr. Peter Verhaert in July 2017, leveraging an acclaimed academic career as Professor Analytical Biotechnology and Innovative Peptide Biology at Delft University of Technology (Delft, NL). Currently Peter Verhaert is honorary Professor Mass Spectrometry Histochemistry at the Multimodal Molecular Imaging Institute of Maastricht University (Maastricht, NL). During his academic career, which spans 35+ years today, Prof. Verhaert has established an impressive professional network, essential for business critical academic as well as industrial collaborations (medical, pharmaceutical as well as technological). For a full company profile, please visit: https://proteoformix.files.wordpress.com/2018/01/180115-profile_proteoformix.pdf.